The role of EMT and MET in cancer dissemination
Jacqueline Banyard1, Diane R Bielenberg1
1a Vascular Biology Program, Department of Surgery , Boston Children's Hospital, Harvard Medical School , Boston , MA , USA.
Abstract:
Metastatic cancer cells are lethal. Understanding the molecular mechanisms that bolster the conversion from benign to malignant progression is key for treating these heterogeneous and resistant neoplasms. The epithelial-mesenchymal transition (EMT) is a conserved cellular program that alters cell shape, adhesion and movement. The shift to a more mesenchymal-like phenotype can promote tumor cell intravasation of surrounding blood vessels and emigration to a new organ, yet may not be necessary for extravasation or colonization into that environment. Lymphatic dissemination, on the other hand, may not require EMT. This review presents emerging data on the modes by which tumor cells promote EMT/MET via microRNA and prepare the pre-metastatic niche via exosomes.
Insights
Metastatic cancer progression involves epithelial-mesenchymal transition (EMT). This review explores how microRNAs and exosomes drive EMT and prepare the pre-metastatic niche for cancer cell spread.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Metastatic cancer is a major cause of cancer-related deaths.
- Understanding the molecular mechanisms of cancer progression is crucial for developing effective treatments.
- The epithelial-mesenchymal transition (EMT) is a key cellular process implicated in cancer metastasis.
Purpose of the Study:
- To review emerging data on the molecular mechanisms driving tumor cell metastasis.
- To elucidate the role of microRNAs (miRNAs) and exosomes in promoting EMT and the pre-metastatic niche.
Main Methods:
- Literature review of recent studies on cancer metastasis, EMT, miRNAs, and exosomes.
- Synthesis of data on the functional roles of miRNAs and exosomes in cancer progression.
Main Results:
- EMT facilitates tumor cell intravasation and dissemination but may not be essential for extravasation or colonization.
- Lymphatic dissemination may occur independently of EMT.
- MicroRNAs and exosomes are key mediators in promoting EMT and establishing the pre-metastatic niche.
Conclusions:
- Targeting miRNA and exosome-mediated pathways could offer novel therapeutic strategies against cancer metastasis.
- Further research into the intricate roles of EMT, miRNAs, and exosomes is warranted for comprehensive cancer treatment.
Related Concept Videos
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Metastasis
The Tumor Microenvironment
Mitogens and the Cell Cycle
Cancer Cell Migration through Invadopodia
Chemotaxis and Direction of Cell Migration


